Related Experiment Video

Updated: May 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Serum small-dense LDL abnormalities in chronic renal disease patients

M Chu1, A Y M Wang, I H S Chan

  • 1Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China.

British Journal of Biomedical Science
|October 13, 2012
PubMed

Insights

Chronic kidney disease (CKD) patients exhibit elevated small-dense low-density lipoprotein (sd-LDL), a key factor in cardiovascular disease (CVD) risk. This study highlights sd-LDL as a crucial marker for CVD assessment in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD) patients.
  • Dyslipoproteinaemia, a metabolic abnormality common in CKD, significantly contributes to CVD risk.

Purpose of the Study:

  • To investigate serum lipoprotein profiles, with a specific focus on small-dense low-density lipoprotein (sd-LDL) abnormalities in CKD patients.
  • To evaluate the potential of sd-LDL as a marker for CVD risk assessment in the CKD population.

Main Methods:

  • Recruited 131 CKD patients and 121 age/gender-matched controls from Hong Kong and Macau.
  • Assayed serum total cholesterol (TC), triglyceride (TG), HDL-C, and direct LDL-C enzymatically.
  • Measured sd-LDL, VLDL, and IDL using FDA-approved polyacrylamide gradient gel electrophoresis.

Main Results:

  • CKD patients exhibited significantly lower TC, LDL-C, normal-size LDL, and HDL-C compared to controls.
  • CKD patients showed significantly increased TG, VLDL, IDL, and sd-LDL (P < 0.01).
  • An elevated sd-LDL:LDL ratio was observed in CKD patients due to increased sd-LDL and decreased normal-size LDL (P < 0.005).

Conclusions:

  • Despite lower overall cholesterol and LDL-C, CKD patients present with significantly elevated sd-LDL and sd-LDL:LDL ratio.
  • sd-LDL is a critical indicator for CVD risk assessment in CKD and other conditions with lipoprotein derangement.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...